PURPOSE: In the United States penile carcinoma is an uncommon malignancy that
represents only 0.4% of all male malignancies and 2% to 4% of genitourinary malignancies …

Background Cancer of the penis is an uncommon malignancy in developed countries, but
the incidence is as high as 17% of all male cancers in some undeveloped countries. The …

PURPOSE: Combination chemotherapy for advanced penile cancer can produce partial
response rates of up to 64%. Complete responses are rare, suggesting a need for adjunct …

Objective To describe both clinical and pathological response rates, survival, and predictors
of survival when using contemporary perioperative chemotherapy and surgical resection for …

Background Penile carcinoma is uncommon in Western countries. Here we report on a large
series of patients with squamous cell carcinoma (SCC) of the penis, describing prognostic …

Cancer of the penis is rare in Europe, accounting for less than 0.5% of all cancers. Phimosis
and poor hygiene are strong risk factors whereas neonatal circumcision is a contributing …

OBJECTIVES: To review the treatment strategies among patients with Stage IV penile
cancer to describe potentially curative or palliative therapy. METHODS: The International …

Squamous cell carcinoma (SCC) is the most common tumor of the penis. The natural history
and its proclivity to spread via regional lymphatics has been well defined. Laser ablation of …

Purpose: The prognosis of patients with advanced squamous cell carcinoma of
genitourinary origin is poor. While single agent chemotherapy results mainly in partial …

PURPOSE: Squamous carcinoma (SCC) of the penis affects about 1 in 100,000 men in
western societies. Interstitial brachytherapy can be an effective penis-conserving modality …